Sutro Biopharma

Sutro Biopharma

Sutro Biopharma

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesistechnology.
Founded
2003
Raised
$164.2M
Follow us
Alexa global traffic share
Latest funding Show all
$85,400,000
Venture capital (Series E) - 2018
Alta Partners Skyline Ventures Lilly Ventures +5
$26,000,000
Venture capital (Series D) - 2013
Celgene Alta Partners Skyline Ventures +3
Team Size
50+
Employees
PE HUB

VC-backed Sutro Biopharma debuts IPO

$85,400,000 Venture capital (Series E)
PE HUB

Sutro Biopharma snags $85.4 mln Series E

Messaging
FinSMEs

Sutro Biopharma Raises $85.4M in Series E Funding Round

Funding Health
Xconomy

Celgene Narrows Its Relationship With Sutro, No Acquisition Coming

Health
$26,000,000 Venture capital (Series D)
FinSMEs

Sutro Biopharma Secures $26M in Series D Financing